Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 3

1(16.7%)

Phase 4

1(16.7%)

6Total

N/A(4)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07240038Recruiting

Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)

Role: collaborator

NCT04831086Phase 3Completed

To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis

Role: collaborator

NCT06840145Not ApplicableCompleted

Biomarkers of Neurodegeneration and Neuroplasticity in Parkinson's Disease Patients Treated by Bilateral M1-iTBS

Role: collaborator

NCT05781243Phase 4Completed

Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation

Role: collaborator

NCT06602635Recruiting

Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS

Role: collaborator

NCT06501404Not ApplicableCompleted

PREMAPROB. Probiotics to Prevent Necrotizing Enterocolitis

Role: collaborator

NCT06327672Recruiting

INOCA Spanish National Registry

Role: collaborator

NCT04218604Not ApplicableCompleted

The Ablate-by-LAW Study

Role: collaborator

NCT03936348Not ApplicableCompleted

Effects of an Exercise Rehabilitation Programme With a Nasal Inspiratory Restriction Device in COPD Patients

Role: collaborator

NCT02057003Unknown

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Role: collaborator

All 10 trials loaded